Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-3-27
|
pubmed:abstractText |
Intracellular accumulation of free or thermosensitive liposome-encapsulated daunorubicin (TLED) at 37 or 43 degrees C, was evaluated using flow cytometry in chemosensitive and P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells. At 37 degrees C, liposome-encapsulation significantly increased intracellular daunorubicin accumulation (IDA) in resistant cells (P=0.005) and that effect was statistically comparable to that achieved in adding 15 micromol/l verapamil to free daunorubicin (DNR). Combining TLED and verapamil further enhanced significantly (P=0.004) this effect as compared to TLED alone. However, none of these treatments restored IDA to the level achieved in sensitive cells. Hyperthermia significantly increased IDA in the sensitive cell (P<0.05), whenever free-DNR or TLED was used, but had no significant effect in the resistant cells, suggesting that P-glycoprotein could efflux the additional drug uptaken in hyperthermic conditions. In all these experiments combining the use of a modulator (verapamil or TLED) and hyperthermia, IDA was statistically comparable to that achieved with free-DNR in sensitive cells at 37 degrees C, but still remained lower than the IDA in sensitive cells at 43 degrees C (P<0.05). The results also showed that hyperthermia affected the labelling of P-glycoprotein by MRK16 monoclonal antibody.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Coloring Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Propidium
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0265-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
855-65
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8586906-Adenocarcinoma,
pubmed-meshheading:8586906-Breast Neoplasms,
pubmed-meshheading:8586906-Coloring Agents,
pubmed-meshheading:8586906-Combined Modality Therapy,
pubmed-meshheading:8586906-Daunorubicin,
pubmed-meshheading:8586906-Drug Carriers,
pubmed-meshheading:8586906-Drug Resistance, Multiple,
pubmed-meshheading:8586906-Female,
pubmed-meshheading:8586906-Flow Cytometry,
pubmed-meshheading:8586906-Fluorescence,
pubmed-meshheading:8586906-Humans,
pubmed-meshheading:8586906-Hyperthermia, Induced,
pubmed-meshheading:8586906-Liposomes,
pubmed-meshheading:8586906-P-Glycoprotein,
pubmed-meshheading:8586906-Propidium,
pubmed-meshheading:8586906-Tumor Cells, Cultured
|
pubmed:articleTitle |
Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia.
|
pubmed:affiliation |
Centre Alexis Vautrin, Laboratoire de Recherche en Oncologie, Vandoeuvre-Les-Nancy, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|